Insider Sales At Phathom Pharmaceuticals Landed A Good Price
While Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) shareholders have had a good week with the stock up 11%, insiders can’t say the same having sold stock over the past year. The value of their investment would have been higher had they waited to sell their stock.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
Phathom Pharmaceuticals Insider Transactions Over The Last Year
Over the last year, we can see that the biggest insider sale was by the insider, Terrie…
